Equity Details
Price & Market Data
Price: $0.0422
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $194,075
Daily Volume: 0
Performance Metrics
1 Week: 101.8%
1 Month: 0.82%
3 Months: -78.15%
6 Months: -91.55%
1 Year: -98.23%
YTD: -75.34%
About Lipella Pharmaceuticals Inc. (LIPO)
Essential market overview for Lipella Pharmaceuticals Inc. (LIPO). Current price: 0.0422, daily change: $0.00 / 0.00%. Market cap: 194,075. All key performance metrics for a full analysis.
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.